Terlipressin is superior to midodrine/octreotide for hepatorenal syndrome type 1

被引：6
|
作者：
Kalambokis, Georgios N. [1 ]
Baltayiannis, Gerasimos [2 ]
Christodoulou, Dimitrios [2 ]
Christou, Leonidas [1 ]
机构：
[1] Univ Ioannina, Med Sch, Div Internal Med 1, GR-45110 Ioannina, Greece
[2] Univ Ioannina, Med Sch, Dept Gastroenterol, Ioannina, Greece
来源：
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY | 2017年 / 29卷 / 12期
关键词：
MANAGEMENT; CIRRHOSIS; ALBUMIN; ASCITES;
D O I：
10.1097/MEG.0000000000000988
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1428 / 1429
页数：2
相关论文
共 50 条
  • [31] Terlipressin and albumin for type-1 hepatorenal syndrome associated with sepsis
    Rodriguez, Ezequiel
    Elia, Chiara
    Sola, Elsa
    Barreto, Rogelio
    Graupera, Isabel
    Andrealli, Alida
    Pereira, Gustavo
    Poca, Maria
    Sanchez, Jordi
    Guevara, Monica
    Soriano, German
    Alessandria, Carlo
    Fernandez, Javier
    Arroyo, Vicente
    Gines, Pere
    JOURNAL OF HEPATOLOGY, 2014, 60 (05) : 955 - 961
  • [32] Octreotide/midodrine therapy significantly improves survival in type 1 hepatorenal syndrome: Analysis of 53 treated patients & 21 controls
    Esrailian, E
    Pantangco, ER
    Kyulo, N
    Hu, KQ
    Runyon, BA
    GASTROENTEROLOGY, 2003, 124 (04) : A718 - A718
  • [33] Octreotide/midodrine therapy significantly improves renal function and 30-day survival in patients with type 1 hepatorenal syndrome
    Esrailian, Eric
    Pantangco, Eugene R.
    Kyulo, Namgyal L.
    Hu, Ke-Qin
    Runyon, Bruce A.
    DIGESTIVE DISEASES AND SCIENCES, 2007, 52 (03) : 742 - 748
  • [34] Noradrenalin Versus the Combination of Midodrine and Octreotide in Patients with Hepatorenal Syndrome: Randomized Clinical Trial
    Tavakkoli, Hamid
    Yazdanpanah, Kambiz
    Mansourian, Marjan
    INTERNATIONAL JOURNAL OF PREVENTIVE MEDICINE, 2012, 3 (11) : 764 - 769
  • [35] TERLIPRESSIN VERSUS MIDODRINE/ OCTREOTIDE AND THE NEED FOR RENAL REPLACEMENT THERAPY
    Yeary, Julianne
    Owen, Emily
    Juang, Paul
    CRITICAL CARE MEDICINE, 2024, 52
  • [36] Noradrenaline as an alternative medical treatment to terlipressin in the management of hepatorenal syndrome type 1
    Sendra, Carmen
    Silva Ruiz, Maria del Pilar
    Ferrer Rios, Maria Teresa
    Alarcon Garcia, Jose Carlos
    Pascasio Acevedo, Juan Manuel
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2018, 41 (07): : 440 - 441
  • [37] Terlipressin and albumin for the hepatorenal syndrome
    Antoniades, C
    Auzinger, G
    HEPATOLOGY, 2003, 37 (04) : 946 - 946
  • [38] Terlipressin (Terlivaz) for Hepatorenal Syndrome
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2023, 65 (1672): : 46 - 48
  • [39] The Use of Terlipressin in Hepatorenal Syndrome
    Rozov-Ung, Inna
    Panesar, Mandip
    DIALYSIS & TRANSPLANTATION, 2010, 39 (10) : 420 - 426
  • [40] Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome:: A retrospective multicenter study
    Moreau, R
    Durand, F
    Poynard, T
    Duhamel, C
    Cervoni, JP
    Ichaï, P
    Abergel, A
    Halimi, C
    Pauwels, M
    Bronowicki, JP
    Giostra, E
    Fleurot, C
    Gurnot, D
    Nouel, O
    Renard, P
    Rivoal, M
    Blanc, P
    Coumaros, D
    Ducloux, S
    Levy, S
    Pariente, A
    Perarnau, JM
    Roche, J
    Scribe-Outtas, M
    Valla, D
    Bernard, B
    Samuel, D
    Butel, J
    Hadengue, A
    Platek, A
    Lebrec, D
    Cadranel, JF
    GASTROENTEROLOGY, 2002, 122 (04) : 923 - 930
12345